Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Liabilities (2020 - 2023)

Terns Pharmaceuticals' Total Liabilities history spans 4 years, with the latest figure at $13.3 million for Q3 2023.

  • For Q3 2023, Total Liabilities rose 49.15% year-over-year to $13.3 million; the TTM value through Sep 2023 reached $13.3 million, up 49.15%, while the annual FY2022 figure was $10.1 million, 29.82% up from the prior year.
  • Total Liabilities reached $13.3 million in Q3 2023 per TERN's latest filing, down from $15.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $119.8 million in Q3 2020 to a low of $6.7 million in Q2 2021.
  • Average Total Liabilities over 4 years is $30.7 million, with a median of $10.1 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: plummeted 93.89% in 2021, then surged 103.39% in 2023.
  • A 4-year view of Total Liabilities shows it stood at $23.7 million in 2020, then plummeted by 67.23% to $7.8 million in 2021, then rose by 29.82% to $10.1 million in 2022, then soared by 31.53% to $13.3 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Total Liabilities are $13.3 million (Q3 2023), $15.5 million (Q2 2023), and $13.6 million (Q1 2023).